Exhaled breath contains thousand metabolites and volatile organic compounds (VOCs) that
originated from both respiratory tract and internal organ systems and their microbiomes …

With heightened global concern of microbial drug resistance, advanced methods for early
and accurate diagnosis of infection are urgently needed. Analysis of exhaled breath volatile …

Chronic pulmonary infections are the principal cause of morbidity and mortality in individuals
with cystic fibrosis (CF). Due to the polymicrobial nature of these infections, the identification …

Pathogenic microorganisms produce numerous metabolites, including volatile organic
compounds (VOCs). Monitoring these metabolites in biological matrices (eg, urine, blood, or …

The identification of bacteria by their volatilomes is of interest to many scientists and
clinicians as it holds the promise of diagnosing infections in situ, particularly lung infections …

Exhaled breath contains thousands of volatile organic compounds (VOCs) of which the
composition varies depending on health status. Various metabolic processes within the …

This review article introduces the significance of testing of volatile organic compounds
(VOCs) in clinical samples and summarizes important features of some of the technologies …

Ideally, invading bacteria are detected as early as possible in critically ill patients: the strain
of morbific pathogens is identified rapidly, and antimicrobial sensitivity is known well before …

Microbial cultures and/or microbial associated diseases often have a characteristic smell.
Volatile organic compounds (VOCs) are produced by all microorganisms as part of their …

The analysis of volatile biomarkers of disease in breath is attractive because breath analysis
is non-invasive and quick, and allows for repeated sampling. Challenges faced in the …